Trademark: 90036867
Status Date
Wednesday, November 8, 2023
Filing Date
Monday, July 6, 2020
Published for Opposition
Tuesday, March 23, 2021
41 Educational services namely, providing online seminars, webinars, lectures, conferences and colloquia in the field of congenital adrenal hyperplasia; Providing an in-person educational forum in the field of congenital adrenal hyperplasia; Educational services, namely providing seminars, webinars, workshops, conferences and colloquia in the field of congenital adrenal hyperplasia; Providing online non-downloadable electronic publications in the nature of brochures, workbooks, newsletters, journals, report, flyers and pamphlets in the field of congenital adrenal hyperplasia; Providing online non-downloadable electronic publications, namely newsletters, articles, studies, reports, journals, magazines, blog posts and pamphlets in the field of congenital adrenal hyperplasia medical research; Providing online non-downloadable electronic training materials in the nature of user manuals in the field of congenital adrenal hyperplasia
9 Downloadable software to enable users to provide and review patient health information and access a patient health registry; downloadable electronic publications in the nature of brochures, workbooks, newsletters, journals, report, flyers and pamphlets in the field of congenital adrenal hyperplasia; Downloadable electronic publications, namely newsletters, articles, studies, reports, journals and pamphlets in the field of congenital adrenal hyperplasia medical research; downloadable software app to enable users to access a patient health registry; Downloadable electronic training materials in the nature of user manuals in the field of congenital adrenal hyperplasia
16 Printed publications in the nature of brochures, workbooks, newsletters, journals, reports, flyers and pamphlets in the field of congenital adrenal hyperplasia; Printed publications, namely newsletters, articles, studies, reports, journals, magazines and pamphlets in the field of congenital adrenal hyperplasia medical research; Printed training materials in the nature of user manuals in the field of congenital adrenal hyperplasia
35 Promoting the interests of people who have congenital adrenal hyperplasia and their families and health care providers by means of public advocacy; maintaining a registry of patients with congenital adrenal hyperplasia; Updating and maintenance of information in registries, namely, administering a patient registry for patients with congenital adrenal hyperplasia
44 Providing medical information; providing a website featuring a registry of patients with congenital adrenal hyperplasia for medical treatment purposes; providing medical and health information to consumers, patients, doctors, and caregivers in the field of congenital adrenal hyperplasia
42 Medical and scientific research services; providing an online computer database that contains data on clinical outcomes, patient-reported outcomes, clinician-reported outcomes, caregiver outcomes and health care resource utilization for medical and scientific research purposes; providing information in the field of medical and scientific research featuring a registry of patients with congenital adrenal hyperplasia; administering a scientific advisory committee in the nature of providing scientific advice and scientific consultation relating to congenital adrenal hyperplasia; hosting an online community website featuring shared communications between community members in the field of congenital adrenal hyperplasia; providing an online community for users to engage with and share information in the field of congenital adrenal hyperplasia; computer services, namely, creating an online community for registered users to participate in discussions, get feedback from their peers, form virtual communities, and engage in social networking services in the field of congenital adrenal hyperplasia; creating an on-line community for doctors, patients, clinicians and caregivers for the purpose of participating in discussions about congenital adrenal hyperplasia
The mark consists of a triangle shape made up of several smaller overlapping blue, yellow, orange, tan, and purple triangles. The color white represents mere transparent background area and is not claimed as a feature of the mark.
The color(s) blue, purple, orange, tan and yellow is/are claimed as a feature of the mark.
Nov 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 8, 2023
Sou Extension 5 Granted
Nov 2, 2023
Sou Extension 5 Filed
Nov 8, 2023
Case Assigned To Intent To Use Paralegal
Nov 2, 2023
Sou Teas Extension Received
May 18, 2023
Notice Of Approval Of Extension Request E-Mailed
May 16, 2023
Sou Extension 4 Granted
May 16, 2023
Sou Extension 4 Filed
May 16, 2023
Sou Teas Extension Received
Oct 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 20, 2022
Sou Extension 3 Granted
Oct 20, 2022
Sou Extension 3 Filed
Oct 20, 2022
Sou Teas Extension Received
May 20, 2022
Notice Of Approval Of Extension Request E-Mailed
May 18, 2022
Sou Extension 2 Granted
May 18, 2022
Sou Extension 2 Filed
May 18, 2022
Sou Teas Extension Received
Nov 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2021
Sou Extension 1 Granted
Nov 16, 2021
Sou Extension 1 Filed
Nov 16, 2021
Sou Teas Extension Received
May 29, 2021
Changes/Corrections After Pub Approval Entered
May 29, 2021
Assigned To Petition Staff
May 18, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 24, 2021
Teas Post Publication Amendment Received
Mar 23, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 23, 2021
Published For Opposition
Mar 3, 2021
Notification Of Notice Of Publication E-Mailed
Feb 17, 2021
Approved For Pub - Principal Register
Feb 12, 2021
Teas/Email Correspondence Entered
Feb 12, 2021
Correspondence Received In Law Office
Feb 12, 2021
Teas Response To Office Action Received
Aug 13, 2020
Notification Of Non-Final Action E-Mailed
Aug 13, 2020
Non-Final Action E-Mailed
Aug 13, 2020
Non-Final Action Written
Aug 13, 2020
Assigned To Examiner
Aug 1, 2020
Notice Of Design Search Code E-Mailed
Jul 31, 2020
New Application Office Supplied Data Entered
Jul 9, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
